scispace - formally typeset
H

Hiroaki Shimokawa

Researcher at Tohoku University

Publications -  976
Citations -  56856

Hiroaki Shimokawa is an academic researcher from Tohoku University. The author has contributed to research in topics: Heart failure & Endothelium. The author has an hindex of 111, co-authored 949 publications receiving 48822 citations. Previous affiliations of Hiroaki Shimokawa include University of Nebraska Medical Center & Nagoya University.

Papers
More filters
Journal ArticleDOI

Coronary microvascular dysfunction in patients with microvascular angina: analysis by TIMI frame count.

TL;DR: Increased TIMI frame count in response to ACh reflects microvascular dysfunction in MVS and that ISDN may not be enough to relieve MVS, suggesting diffuse impaired coronary microcirculation in the myocardium.
Journal ArticleDOI

Prostacyclin does not inhibit rho-kinase: an implication for the treatment of pulmonary hypertension.

TL;DR: It is suggested that combination therapy with prostacyclin and a Rho-kinase inhibitor could exert further beneficial effects on PH.
Journal ArticleDOI

γ-Tocopherol, but not α-tocopherol, potently inhibits neointimal formation induced by vascular injury in insulin resistant rats

TL;DR: Greek tocopherol, but not α-tocopherol, reduces the neointima proliferation in insulin resistance, independently of its effects on superoxide production and related with its inhibitory effects on nitrosative stress.
Journal ArticleDOI

Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension.

TL;DR: Results indicate that RV remodeling occurs early during PH development through fibrosis, perivascular remodeling, capillary rarefaction and autophagy, in which the eNOS pathway and collagen metabolism might be involved.
Journal ArticleDOI

Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway.

TL;DR: In this article, Paclitaxel-eluting stent (PES) and a BMS were randomly implanted in the left coronary arteries in male domestic pigs with and without long-acting nifedipine (NIF, 4 mg/kg/day) for 4 weeks (n = 7 each).